Symbol="HOWL"
AssetType="Common Stock"
Name="Werewolf Therapeutics Inc"
Description="Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapies designed to boost the body's immune system for the treatment of cancer. The company is headquartered in Cambridge, Massachusetts."
CIK="1785530"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1030 MASSACHUSETTS AVENUE, SUITE 210, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="97219000"
EBITDA="-51482000"
PERatio="None"
PEGRatio="None"
BookValue="3.426"
DividendPerShare="0"
DividendYield="0"
EPS="-1.41"
RevenuePerShareTTM="0.679"
ProfitMargin="-2.418"
OperatingMarginTTM="-2.536"
ReturnOnAssetsTTM="-0.184"
ReturnOnEquityTTM="-0.388"
RevenueTTM="20865000"
GrossProfitTTM="-37360000"
DilutedEPSTTM="-1.41"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="12.06"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="6.61"
PriceToBookRatio="0.42"
EVToRevenue="0.157"
EVToEBITDA="1.17"
Beta="0.19"
num_52WeekHigh="7.51"
num_52WeekLow="1.39"
num_50DayMovingAverage="3.122"
num_200DayMovingAverage="2.797"
SharesOutstanding="35611400"
DividendDate="None"
ExDividendDate="None"
symbol="HOWL"
open="2.86"
high="2.93"
low="2.72"
price="2.73"
volume="64959.00"
latest_trading_day="2023-07-28"
previous_close="2.73"
change="0.00"
change_percent="0.0000%"
aroon_positive_momentum_days="67"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="67"
Volume_recent_avg="44111"
Change_recent_avg="-0.02"
Delta_recent_avg="0.25"
Variance_recent_avg="0.12"
Change_ratio_recent_avg="-0.65"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_45"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="67"
Aroon_momentum_negative="33"
image_negative_thumbnail_id_1="1107"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0140.jpeg"
image_negative_thumbnail_id_2="125"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0051.jpeg"
image_neutral_thumbnail_id_1="532"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0067.jpeg"
image_neutral_thumbnail_id_2="526"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0073.jpeg"
image_positive_thumbnail_id_1="648"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0060.jpeg"
image_positive_thumbnail_id_2="991"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0153.jpeg"
image_professor_thumbnail_id_1="1173"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
image_professor_thumbnail_id_2="1181"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
